FIRMANI LORI (Interim CFO) sold 17.5% of their position (147.00 shares) of DAMORA THERAPEUTICS, INC. on the open market
Open‑market sale worth $498.33 — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/8/2025ACC: 0000950170-25-094572
Officer· Interim CFO
Since Aug 2024
-147.00
Net shares
Net seller
$498.33
Total sold
1
Open market trades
0B · 1S
3
Total transactions
374.00 acquired · 521.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+374.00
Price / share
—
Trade value
—
% of position
80.4%
7/3/2025
465.00→839.00
Common Stock
Direct
Shares
−147.00
Price / share
$3.39
Trade value
$498.33
% of position
17.5%
7/3/2025
839.00→692.00
Total
Net shares
+227.00
Net value
-$498.33
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/3/2025 | M · Option Exercise | +374.00 | — | — | 80.4% | 465.00 | 839.00 |
| Common Stock Direct | 7/3/2025 | S · Sale | −147.00 | $3.39 | $498.33 | 17.5% | 839.00 | 692.00 |
| Total | +227.00 | -$498.33 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
374.00 shares
Shares
−374.00
Strike price
Held after
1.10K
Exercisable
—
7/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock374.00 shares | 7/3/2025 | M · Option Exercise | −374.00 | — | 1.10K |